Investigation With BiopH+Psoriasis Medical Bath in Subject With Mild to Moderate Plaque Psoriasis.
NCT05046899 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2022-10-06
Summary
The purpose of this investigation is to assess performance and safety of BIOpH+ Psoriasis Medical Bath in comparison to a comparative device.
Conditions
Interventions
- DEVICE
-
BIOpH+ Psoriasis Medical Bath
20 min bath every day during 1 week and thereafter 20 min bath every second day for additional 7 weeks.
- DEVICE
-
Cetaphil Moisturizing Lotion
Cetaphil Moisturizing Lotion will be applied on the affected body area on the same days as the BIOpH+ Psoriasis Medical Bath is performed.
Sponsors & Collaborators
-
Biocool AB
lead INDUSTRY
Principal Investigators
-
Martin Lundvall, MD · Research Unit, University Hospital Örebro, Sweden
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-09-14
- Primary Completion
- 2022-05-31
- Completion
- 2022-06-13
Countries
- Sweden
Study Locations
More Related Trials
-
The Safety & Efficacy of Etanercept in Psoriasis Patients Who Have Not Responded to Adalimumab
NCT00833729 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)
NCT02326272 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is
NCT03835481 ·Status: TERMINATED ·Phase: PHASE2
-
This Study is Done in Patients With Plaque Psoriasis and Tests How Well They Tolerate BI 730357 and How Effective it is
NCT03635099 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate ABY-035 in Subjects With Moderate-to-severe Plaque Psoriasis
NCT03591887 ·Status: COMPLETED ·Phase: PHASE2
-
Open Label Continuation Study in Moderate to Severe Psoriasis
NCT00626002 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of ABT-874 in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00292396 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Efficacy and Safety of MP1032 in Patients With Chronic Plaque Psoriasis
NCT03706209 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of JNJ-77242113 in Participants With Moderate-to-severe Plaque Psoriasis
NCT05223868 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing Efficacy and Safety of Bmab 1200 and Stelara in Patients With Moderate to Severe Chronic Plaque Psoriasis
NCT05335356 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)
NCT02346240 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of CC-90006 in Subjects With Mild to Moderate Plaque-type Psoriasis
NCT03337022 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment on Efficacy and Safety of BAT2306 and Cosentyx® in Plaque Psoriasis Patients
NCT05377944 ·Status: COMPLETED ·Phase: PHASE3
-
Double-Blind Study of Topical WBI-1001 Cream on Patients With Psoriasis
NCT00830817 ·Status: COMPLETED
-
Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis
NCT01690299 ·Status: COMPLETED ·Phase: PHASE3
-
Exploration of the Cellular and Molecular Mechanisms in Patients Receiving Biotherapies Targeting the IL-23/IL-17 Axis in Cutaneous Psoriasis
NCT05111210 ·Status: RECRUITING
-
Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00691964 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Test How Well Different Doses of BI 765250 Are Tolerated by People With a Skin Disease Called Plaque Psoriasis
NCT05728489 ·Status: COMPLETED ·Phase: PHASE1
-
Multiple Dose Escalation Study In Medically Stable Subjects With Psoriasis
NCT01736696 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)
NCT05509023 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)
NCT00096928 ·Status: COMPLETED
-
A Study of HS-20137 in Participants with Moderate-to-severe Plaque Psoriasis
NCT06844799 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis
NCT00540618 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
NCT07129382 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Efficacy Study of CDP870 in Subjects With Chronic Plaque Psoriasis Who Are Candidate for Systemic Therapy and/or Phototherapy/Photochemotherapy
NCT00245765 ·Status: COMPLETED ·Phase: PHASE2